Cargando…
Ceftazidime Is the Key Diversification and Selection Driver of VIM-Type Carbapenemases
In recent decades, carbapenems have been considered the last line of antibiotic therapy for Gram-negative bacterial infections. Unfortunately, strains carrying a high diversity of β-lactamases able to hydrolyze carbapenems have emerged in the clinical setting. Among them, VIM β-lactamases have diver...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Microbiology
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941070/ https://www.ncbi.nlm.nih.gov/pubmed/29739906 http://dx.doi.org/10.1128/mBio.02109-17 |